Trailhead Biosystems, Inc. (trailbio.com), a biotechnology company creating iPSC-derived human cells at scale for drug discovery and cell therapy, welcomes Josh Snow as Chief Commercial Officer.

Researchers have developed an artificial intelligence which can differentiate cancer cells from normal cells ... regular microscopes can see. The high-definition snapshots reveal structures ...

For the first time, researchers have implicated the gene CHCHD2 in Huntington's disease (HD)—an incurable genetic ... led by Dr. Jakob Metzger of the Quantitative Stem Cell Biology lab at ...

(Unsplash) Researchers have discovered the gene CHCHD2 as a possible novel treatment target and have linked it for the first time to Huntington's Disease (HD), an incurable inherited neurological ...

Background Huntington’s disease (HD) is a potential indication for regenerative medicine ... Effective neurorestorative or neurodegenerative strategies based on human stem cell products offers a ...

The human brain could hold one petabyte of data — equivalent to all the movies ever made and in HD.

Researchers uncover CHCHD2s role in Huntingtons Disease revealing new insights and potential therapies for early detection ...

USF faculty continually demonstrate their skills in conducting high-impact research and innovation to advance frontiers of ...

RNA vaccines have gained widespread attention for their crucial role in fighting the COVID-19 pandemic. Yet, even before the ...

impact on the vascular system and infection in multiple organs vulnerable to cancer stem cell development — he kept thinking ...